Cancer Research
- CB1400, Patented By Canopus BioPharma, Enters Phase II Clinical Trials For The Prevention Of Mucositis In Patients With Cancer O
-
Contact: Len Rothstein, President, Tel. +1-818-980-5008, Fax. +1-818-980-5088, len@canopusbiopharma.com ...
Article - Anna Ohlden - Jun 23 2008 - 7:30am
- Prostate Cancer: NICE Clarification Boosts NHS Treatment Options
-
http://www.galilmedical.com. For further information, please contact Helena Symeou at hsdcommunications on: +44(0)1923-777277 ...
Article - Anna Ohlden - Jun 27 2008 - 10:32am
- Carna Biosciences Signs Reagent Supply Agreement With Caliper Life Sciences
-
solutions. Contact: Tomohisa Yamazaki, Manager Corporate Planning Carna Biosciences, Inc. Phone: ...
Article - Anna Ohlden - Aug 8 2008 - 2:34am
- Dangerous Side-Effects Of Epilepsy Drugs Reduced In New Research
-
9 August 2008. For media enquiries please contact: The British Pharmaceutical Conference 2008 Press Office ...
Article - Anna Ohlden - Sep 8 2008 - 12:32am
- Diva TV Announces Stand Up 2 Cancer Special
-
Sky (channel 282) and Virgin Media (channel 192). For further information please contact Chloe ...
Article - Anna Ohlden - Sep 11 2008 - 9:31am
- Cancer-Causing Gut Bacteria Implicated
-
in the colon where billions of bacteria are in contact with the gut surface. For years scientists ...
Article - News Staff - Sep 21 2008 - 2:32pm
- CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
-
and IBA: http://www.iba-worldwide.com. Chromoa(TM) is a trademark of CISBIO Bioassays. Media Contact ...
Article - Anna Ohlden - Sep 23 2008 - 11:31am
- Lumiphore Partners With Biophor Diagnostics, Inc. To Develop Tests For Drugs Of Abuse; Appoints Ibis Biosciences Founder David J
-
of Lumiphore, Inc. CONTACT: Stephen Blose, +1-415-381-4457, for Lumiphore, Inc. Web site: ...
Article - Anna Ohlden - Oct 1 2008 - 1:30am
- Cancer Stem Cells Stifle Immune Response To Glioblastoma Multiforme
-
suicide. This is accomplished via the immunosuppressive protein B7-H1 in the stem cells directly contacting ...
Article - News Staff - Jan 15 2010 - 2:48pm
- Long-term Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement
-
these 40,000 potential respondents, approximately 19,000 had confirmable contact information. Contact ...
Article - News Staff - May 24 2007 - 1:35am
Know Science And Want To Write?
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
